Epidermic necrolysis: advances in pathogenesis.
Roujeau
J C
JC
Service de Dermatologie, Hôpital Henri-Mondor, Université Paris XII, 94010 Créteil Cedex.
D000328:Adult; D000954:Antigens, Surface / Q000502:physiology; D017209:Apoptosis / Q000502:physiology; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D053222:Fas Ligand Protein; D006801:Humans; D008024:Ligands; D008264:Macrophages / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D019014:fas Receptor / Q000502:physiology
D000954:Antigens, Surface; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008024:Ligands; D008562:Membrane Glycoproteins; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor
Nécrolyse épidermique: les advancées physiopathogéniques.